2008
DOI: 10.1016/j.molimm.2007.04.027
|View full text |Cite
|
Sign up to set email alerts
|

IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
53
0
3

Year Published

2008
2008
2018
2018

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 61 publications
(59 citation statements)
references
References 38 publications
3
53
0
3
Order By: Relevance
“…In addition, both IL-23 and IL-17 promote expression of matrix metalloproteinase-9 (MMP-9) function while IL-17 alone promotes myeloperoxidase (MPO) activity. Zelante et al [5] also mention that addition of IL-23 or IL-17 resulted in reduced apoptosis, which has recently been reported for IL-17 [12]. These changes in neutrophil function and survival resulting from exposure to IL-23 or IL-17 may reconcile the data shown here with that from the IL-17ARKO mouse [7].…”
supporting
confidence: 77%
“…In addition, both IL-23 and IL-17 promote expression of matrix metalloproteinase-9 (MMP-9) function while IL-17 alone promotes myeloperoxidase (MPO) activity. Zelante et al [5] also mention that addition of IL-23 or IL-17 resulted in reduced apoptosis, which has recently been reported for IL-17 [12]. These changes in neutrophil function and survival resulting from exposure to IL-23 or IL-17 may reconcile the data shown here with that from the IL-17ARKO mouse [7].…”
supporting
confidence: 77%
“…4). It has also been suggested that IL-17 may have a regulatory function limiting the accumulation and or activity of neutrophils during inflammation, by attenuating the anti-apoptotic effect of inflammatory cytokines [86]. IL-17R-defective mice had reduced CXC chemokine production, neutrophil recruitment and increased bacterial load and mortality following challenge with K. pneumoniae [13].…”
Section: Role Of Il-17-secreting T Cells In Infectionmentioning
confidence: 99%
“…Subcutaneous injection of IL-17A into mice causes neutrophilia, which occurs by acceleration of neutrophil formation from committed progenitors and by enhanced chemotaxis [37,38]. In addition, IL-17A is able to directly inhibit apoptosis of neutrophils in inflamed tissues [39]. IL-17A also enhances angiogenesis [40] and mediates tissue remodeling by stimulating the production of angiogenic factors and matrix metalloproteases [41].…”
Section: Th17 Effector Cytokines: Il-17a Il-22 and Il-21mentioning
confidence: 99%